Julianne Bruno

Insider Reports History

Location
C/O Crispr Therapeutics, 105 West First Street, Boston, MA
Signature
/s/ Lori Firmani, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Julianne Bruno:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CRISPR Therapeutics AG Chief Operating Officer Common Shares 10.5K $435K $41.23 Mar 21, 2025 Direct
CRISPR Therapeutics AG Chief Operating Officer Common Shares 7.09K $292K $41.23 Mar 20, 2025 The Julianne Bruno 2022 GRAT
Galecto, Inc. Director Common Stock 8.03K $60K $7.47 Nov 10, 2025 Direct
CRISPR Therapeutics AG Chief Operating Officer Stock Option (Right to Buy) 36.7K Mar 14, 2025 Direct
CRISPR Therapeutics AG Chief Operating Officer Restricted Stock Units 11.3K Mar 20, 2025 Direct

Insider Reports Filed by Julianne Bruno

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GLTO Galecto, Inc. Nov 10, 2025 0 $0 3 Nov 17, 2025 Director
CRSP CRISPR Therapeutics AG Mar 20, 2025 3 -$70.7K 4 Mar 24, 2025 Chief Operating Officer
CRSP CRISPR Therapeutics AG Mar 14, 2025 2 $0 4 Mar 18, 2025 Chief Operating Officer
CRSP CRISPR Therapeutics AG Mar 10, 2025 6 -$59K 4 Mar 12, 2025 Chief Operating Officer
CRSP CRISPR Therapeutics AG Feb 18, 2025 3 -$17.6K 4 Feb 19, 2025 Chief Operating Officer
CRSP CRISPR Therapeutics AG Oct 16, 2024 1 $0 4 Oct 18, 2024 Chief Operating Officer
CRSP CRISPR Therapeutics AG Jun 20, 2024 3 -$189K 4 Jun 24, 2024 Chief Operating Officer
CRSP CRISPR Therapeutics AG May 23, 2024 1 $0 4 May 24, 2024 Chief Operating Officer
CRSP CRISPR Therapeutics AG May 23, 2024 0 $0 3 May 23, 2024 Chief Operating Officer